• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand

    Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status

    All Eyes on Vision Health

    Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

    Vitamin D: A Fixture of Supplementation and Fortification
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    ADM Expands Production to Meet Demand for Probiotics

    Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA

    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder

    Overall Health, Immune Support, and Mental Wellness Drive VMS Usage

    NPA Announces Annual Capitol Hill Advocacy ‘Fly-In’ Day
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Rhodiola Added to CITES List of Protected Species

    ADM Expands Production to Meet Demand for Probiotics

    Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA

    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Rhodiola Added to CITES List of Protected Species

    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder

    Overall Health, Immune Support, and Mental Wellness Drive VMS Usage

    NPA Announces Annual Capitol Hill Advocacy ‘Fly-In’ Day

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA

    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder

    Overall Health, Immune Support, and Mental Wellness Drive VMS Usage

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets

    Lallemand Health Solutions Debuts Organic Saccharomyces Boulardii Probiotic Yeast
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Chenguang Biotech Group Co., Ltd.

    EIRICH Machines

    Nutrition21, LLC

    Sabinsa Corporation

    Botanic Healthcare LLC
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Chenguang Biotech Group Co., Ltd.

    EIRICH Machines

    Nutrition21, LLC

    Sabinsa Corporation

    Botanic Healthcare LLC
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research

    UK-based company has pioneered cannabis-based drug development for serious conditions.

    GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research
    Related Content
    • FDA Stance on CBD Requires Congress to Intervene
    • Personalized Health & The Future of Cannabis
    • Sunflower Hemp Co
    • FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs
    • FDA Rejects Two New Dietary Ingredient Notifications for CBD
    03.25.19
    The American Botanical Council (ABC) presented its 2018 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award to Cambridge, England-based GW Pharmaceuticals. Founded in 1998, the company’s “focus is to bring novel, cannabinoid-based prescription medicines to patients in areas of serious unmet need and in which our medicines have the potential to make a real difference to their quality of life,” according to its website. GW has a U.S. subsidiary, Greenwich Biosciences, based in California.

    The ABC Tyler Award was created to honor one of the most respected educators in late-20th century herbal medicine and pharmacognosy (the science related to drugs derived from plants and other natural sources). Varro E. Tyler, PhD, who died in 2001, was vice president of academic affairs at Purdue University and dean of the College of Pharmacy and Pharmaceutical Sciences at Purdue for 20 years. He was the senior author of six editions of a leading pharmacognosy textbook and numerous other professional and popular books and academic articles. Tyler, an early member of ABC’s board of trustees, encouraged scientific and product integrity and envisioned a rational phytomedicinal health care sector that valued the proper evaluation of botanical products’ quality, safety, and efficacy.

    “GW Pharmaceuticals is extremely honored to receive this prestigious award recognizing our many years of cutting-edge research in the field of cannabis-derived medications,” said Justin Gover, CEO of GW. “Professor Tyler was a great pioneer in the field of pharmacognosy, and, like him, we believe that plants, like cannabis, have vast therapeutic potential. Our work demonstrates that, with rigorous research and the advent of new scientific techniques, the cannabis plant can form the basis for new prescription medicines that have the potential to make a meaningful impact on patients’ lives. We are committed to continuing our research into the therapeutic applications of cannabis and cannabinoids for many years to come.”

    GW is especially known for the development of two phytomedicines from cannabis (Cannabis sativa). First, Sativex, a standardized complex botanical mixture delivered as an oromucosal spray that has been approved in more than 25 countries outside the U.S. to treat multiple sclerosis-related spasticity, is the world’s first cannabis-derived prescription medicine, according to the company. Sativex contains equal parts of cannabidiol (CBD, the most-studied non-intoxicating compound in cannabis) and tetrahydrocannabinol (THC, the main intoxicating compound in cannabis). The US Food and Drug Administration (FDA) has not approved Sativex. But, according to Alice Mead, vice president of U.S. public policy and public affairs at Greenwich Biosciences, GW expects to begin a phase 3 clinical trial in the U.S. later in 2019. The trial will investigate Sativex’s effects in patients with multiple sclerosis, and the company hopes it will lead to FDA approval.

    Second, Epidiolex is a standardized oil-based CBD oral solution. In June 2018, the FDA approved Epidiolex for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome, two rare, severe, early-onset forms of epilepsy, both with frequent, difficult-to-control seizures of multiple types. Epidiolex is the first drug approved by the FDA for the treatment of Dravet syndrome and is also the first cannabis-derived prescription medicine available in the U.S. Additionally, it represents a new class of antiseizure medication.

    The FDA’s approval was prompted, at least partly, by three randomized, double-blind, placebo-controlled clinical trials on Epidiolex (all funded by GW). In these trials, patients in the Epidiolex group experienced statistically significant reductions in seizure frequency compared to those taking placebo. Importantly, these patients otherwise had been unable to achieve seizure control with their standard treatment regimens.

    According to Mead, GW has invested more than $1 billion on research and development. The company is also developing other cannabinoid product candidates, with a focus on neurological conditions.

    GW grows its cannabis in greenhouses that control temperature, humidity, and lighting, and the company does not use pesticides or fungicides. The company has bred a proprietary chemovar (chemical variety) of cannabis that has higher levels of CBD and lower levels of THC. It has been growing the plants in-house for more than 20 years.

    Stefan Gafner, PhD, chief science officer of ABC, said: “The clinical work by GW Pharmaceuticals has led to effective therapeutic agents to reduce spasticity in multiple sclerosis patients and treat Lennox-Gastaut and Dravet syndromes. However, the impact of its research cannot be measured solely by the patient benefits. The company’s pioneering work on Cannabis sativa has helped to destigmatize the plant and has opened the door for additional research, which will hopefully lead to treatment successes for other diseases in which effective therapies are desperately needed.”

     
    Related Searches
    • Research
    • Botanical
    • Natural
    • fda
    Related Knowledge Center
    • Regulations
    • Healthcare Trends
    • Research
    • World Markets
    • Herbs & Botanicals
    Suggested For You
    FDA Stance on CBD Requires Congress to Intervene FDA Stance on CBD Requires Congress to Intervene
    Personalized Health & The Future of Cannabis Personalized Health & The Future of Cannabis
    Sunflower Hemp Co Sunflower Hemp Co
    FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs
    FDA Rejects Two New Dietary Ingredient Notifications for CBD FDA Rejects Two New Dietary Ingredient Notifications for CBD
    Shinhigh International Corp Won BHB Patent Lawsuit Shinhigh International Corp Won BHB Patent Lawsuit
    Jim Emme to Receive American Botanical Council Champion Award for 2018 Jim Emme to Receive American Botanical Council Champion Award for 2018
    Afrigetics Botanicals Sponsors Bulbine through ABC’s Adopt-an-Herb Program Afrigetics Botanicals Sponsors Bulbine through ABC’s Adopt-an-Herb Program
    ABC Updates Monograph on Scientific and Clinical Research on Pycnogenol ABC Updates Monograph on Scientific and Clinical Research on Pycnogenol
    Natural Remedies Supports ABC’s Adopt-an-Herb Program Through Licorice Adoption Natural Remedies Supports ABC’s Adopt-an-Herb Program Through Licorice Adoption
    2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD 2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD
    ABC’s Gayle Engels to Receive Inaugural Award for Excellence in Herbal Education ABC’s Gayle Engels to Receive Inaugural Award for Excellence in Herbal Education
    Botanical Adulterants Prevention Program Publishes Cranberry Laboratory Guidance Document Botanical Adulterants Prevention Program Publishes Cranberry Laboratory Guidance Document
    Demystifying the Regulatory Status of CBD Demystifying the Regulatory Status of CBD
    Applied Food Sciences Launching Free-Flowing Curcumin Applied Food Sciences Launching Free-Flowing Curcumin

    Related Editorial

    • Herbs & Botanicals | Quality & Safety | Regulations
      FDA Stance on CBD Requires Congress to Intervene

      FDA Stance on CBD Requires Congress to Intervene

      It’s high time for Congress to clarify its intentions on hemp and CBD, and (ultimately) to legalize cannabis at the federal level.
      By Sean Moloughney, Editor 11.04.21

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Natural/Organic
      Personalized Health & The Future of Cannabis

      Personalized Health & The Future of Cannabis

      Len May, CEO & co-founder of EndoCanna Health, discusses his journey with cannabis and its potential to improve health for others.
      By Sheldon Baker, CEO of the Baker Dillon Group LLC 10.08.21

    • Sunflower Hemp Co

      ...
      Colby Terip, Owner 09.15.21


    • Herbs & Botanicals | Quality & Safety | Regulations
      FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs

      FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs

      Multicomponent hemp extracts with trace levels of THC and other naturally occurring compounds have not been approved in any new drug.
      By Todd Harrison, Venable 09.09.21

    • Herbs & Botanicals | Quality & Safety | Regulations | Regulatory News
      FDA Rejects Two New Dietary Ingredient Notifications for CBD

      FDA Rejects Two New Dietary Ingredient Notifications for CBD

      The decision likely means the agency will not approve future NDIs for CBD barring a directive from Congress.
      By Mike Montemarano, Associate Editor 08.13.21

    Loading, Please Wait..
    Trending
    • Vitamin D Supplementation Reduces Risk Of Dynapenia
    • Study Examines Vitamin K2 Content In Cheese
    • NOW Switches To Bottles Made From 100% Post-Consumer Recycled Resin
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    Breaking News
    • ADM Expands Production to Meet Demand for Probiotics
    • Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA
    • FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder
    • Overall Health, Immune Support, and Mental Wellness Drive VMS Usage
    • NPA Announces Annual Capitol Hill Advocacy ‘Fly-In’ Day
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2023

    • Healthy, Clean Label Snacks and Nutrition Bars Help Fill Nutrient Gap Cleaved By Modern Lifestyles
    • Magnesium: An Essential Mineral with Many Forms and Functions
    • Vitamin D: A Fixture of Supplementation and Fortification
    • Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    • All Eyes on Vision Health
    • Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    ADM Expands Production to Meet Demand for Probiotics
    Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA
    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder
    Coatings World

    Latest Breaking News From Coatings World

    Personnel Changes at BASF
    Dr. Kurt Wood to Deliver Mattiello Memorial Lecture at ACA’s 2023 CoatingsTech Conference
    hubergroup Chemicals to Debut at the European Coatings Show
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Konica Minolta Introduces Mobile X-Ray Systems to Latin America
    NIH MedTech Program Aims to Develop Neurological Treatment Tech
    Formula Plastics Appoints Bill Gerard as President
    Contract Pharma

    Latest Breaking News From Contract Pharma

    ValiRx Signs Lease Deal with Nottingham Laboratories
    Civica Partners with Ypsomed for Insulin Injection Pen
    Charles River Laboratories Completes the Acquisition of SAMDI Tech
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Tree Hut Introduces Body Wash Line
    Zara Introduces Mini Artists—Beauty Products for Kids
    L’Oréal USA Taps Stephanie Kramer as Chief Human Resources Officer
    Happi

    Latest Breaking News From Happi

    FTC Extends Public Comment Period on Potential Updates to Green Guides
    Arm & Hammer Taps Dave & Jenny Marrs, TikTokers for Budget-Centered 'Give It The Hammer' Campaign
    Meaningful Beauty Age-Proof Hair Care System Now Available on Amazon
    Ink World

    Latest Breaking News From Ink World

    Siegwerk, Wildplastic, TU-Hamburg Partner on Deinking
    Brilliant Group and Terra Firm Launch Partnership
    hubergroup Chemicals Debuts at the European Coatings Show
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    The Oldham Group names Doug McClure technical sales rep
    Siegwerk partnership aims to improve plastic waste recyclability
    CELAB-Europe launches new web hub for liner recyclers
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Hospeco Offers TaskBrand Prep-Paint-Finish Wiping System
    Toray to Expand PPS Production in Korea
    Masque Bar Launches Compostable Sheet Masks
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OSSIO Introduces Non-Permanent Compression Staple
    Dennis Jones Joins Intelivation Technologies as Manufacturing VP
    Jury Convicts Chiropractor, Orthopedic Surgeon in $31M Fraud Scheme
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Technologies Extends Partnership with the NFL
    OE-A at LOPEC – Printed Electronics Up Close
    Monthly Recap: LG OLED, Avery Dennison and JOLED Top This Month’s Stories

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login